GO
Loading...

GSK Will Defend Tier Pricing: CEO

Thursday, 18 Oct 2012 | 7:40 PM ET

Andrew Witty, Global CEO, GlaxosmithKline speaks to CNBC TV-18's Shereen Bhan on the current patent price debate in the drug industry. He states GSK will continue striving to defend tier pricing.